Results: Platelet 5-HT concentration was significantly higher in veterans with psychotic PTSD than in veterans with non-psychotic PTSD, veterans without PTSD, or in control subjects.
Introduction
Posttraumatic stress disorder (PTSD) occurs after an extreme, life threatening traumatic event. Combat-related PTSD is a severe form of PTSD, sometimes associated with psychotic symptoms (Hamner, 1997; Hamner et al., 1999) . The underlying neurobiological dysfunction of PTSD includes the abnormalities in different neurotransmitter and neuroendocrine systems (Morgan III et al., 2003) . Serotonin (5-hydroxytryptamine, 5-HT) is implicated in the pathophysiology of PTSD, since 5-HT alterations might contribute to the cognitive disturbances in PTSD (van Praag, 2004) and aggression (Goveas et al., 2004) , 5-HT drugs (sertraline) show clinical efficacy of in the treatment of PTSD (Brady et al., 2000) , and administration of the 5-HT 2 agonist meta-chlorophenylpiperazine provokes PTSD symptoms (Southwick et al., 1997) .
Blood platelets share similarities (receptors, transporter, uptake, storage and release of 5-HT) with the central 5-HT synaptosomes (Camacho and Dimsdale, 2000; Stahl, 1985) , and platelet 5-HT has been associated with depressive symptoms in PTSD (Muck-Seler et al., 2003) , and aggression (Goveas et al., 2004) . Since biological markers are associated to single psychological dysfunction (Mueller-Oerlinghausen et al., 2004; van Praag, 2004) , we hypothesized that platelet 5-HT concentration might be related with specific PTSD or psychotic symptoms in patients with combat related PTSD. The aim of the study was to evaluate the association between particular PTSD or psychotic symptoms, and platelet 5-HT concentration, in drug-free male war veterans with combat related PTSD, combat-exposed war veterans who did not develop PTSD, war veterans who had PTSD complicated with psychotic symptoms, and in healthy male control subjects.
Materials and methods
Participants were 39.4 ± 7.1 years old (range 24-56 years) male, drug-free war veterans (N=138) with chronic and current combat related PTSD, hospitalized at the Department of Psychiatry, University Hospital Dubrava, during 2001-2004 period. Diagnosis of chronic and current combat related PTSD was established using Structured Clinical Interview (SCID) based on DSM-IV criteria (APA, 1994) . Groups were divided into 67 veterans with PTSD, 35 veterans with psychotic PTSD, and 36 veterans who did not develop PTSD. PTSD and psychotic symptoms were assessed with Clinician Administrated PTSD Scale (CAPS) (Weathers et al., 2001) , and Positive and Negative Syndrome Scale (PANSS) 4 4 (Kay et al., 1987) . Only patients with total Hamilton Rating Scale for Depression (HAMD) scores ≤ 18 (Hamilton, 1960) were included. The onset of PTSD in psychotic PTSD patients preceded the onset of psychosis. Psychotic symptoms (hallucinations or delusions on the psychotic module of the SCID, or specific disturbance in form of thoughts by mental status examination) and exclusion/inclusion criteria were described in our previous papers (Pivac et al., 2004a; . The procedure was fully explained and written informed consent was obtained from all patients. Human ethics committee of the University Hospital Dubrava approved this protocol.
Control group consisted of 136 male drug-free healthy controls, mainly medical stuff, with no personal or family history of psychopathology, substance abuse or dependence, and no medical treatment. Veterans and healthy controls were sampled in the same period of the year.
Blood (4 ml) was drawn from cubical vein at 8.00 a.m. in a plastic syringe with 1 ml of acid citrate dextrose (ACD) anticoagulant. Platelet 5-HT concentrations were determined by the spectrofluorimetric method, as described before (Pivac et al., 2004b) . Platelet protein was determined by the method of Lowry et al. (1951) .
Statistical evaluation of the results, expressed as means ± SD, was done using one-way analysis of variance (ANOVA), followed by a Tukey's multiple comparison test, and correlations were determined by a Pearson's coefficient of correlation. The significance was accepted when p<0.05.
Results
The demographic data are presented in Table 1 . Platelet 5-HT concentration differed significantly (F(3,266)=3.387, p=0.019), with significantly (Tukey's test) higher platelet 5-HT concentration in veterans with psychotic PTSD than in veterans with PTSD (p=0.019), without PTSD (p=0.040), or in control subjects (p=0.029). Platelet 5-HT concentration did not differ significantly (p>0.05) between control subjects, veterans with PTSD or veterans who did not develop PTSD (Fig. 1) .
Age of the subjects (Table 1 ) differed significantly (F(3,266)=10.839, p=0.000), and control subjects (33.04 ± 11.24 years) were significantly (Tukey's test) younger than veterans with PTSD (p=0.000), without PTSD (p=0.037), or with psychotic PTSD (p=0.019).
No significant correlation was found between platelet 5-HT concentration and age in control subjects (r=-0.013; p=0.909), veterans with PTSD (r=0.078; p=0.531), without PTSD (r=-0.023; p=0.896), or with psychotic PTSD (r=-0.222; p=0.208). (Table 2 ).
Discussion
Our results showed that platelet 5-HT concentration was increased in drug-free veterans with chronic and current combat related PTSD complicated with psychotic features, when compared to veterans with or without PTSD, or to control subjects. A positive correlation was found between platelet 5-HT and positive symptoms listed in PANSS subscale, and this correlation was due to the relationship between increased platelet 5-HT and delusions.
The highest platelet 5-HT concentration was found in psychotic PTSD patients with delusions. This finding agrees with the association between platelet 5-HT content and aggression (Goveas et al., 2004) , impulsivity and violence (Askenazy et al., 2000) , psychotic symptoms of depression (Muck-Seler et al., 1996a; Pivac et al., 1997a) , delusions in dementia (Meszaros et al., 1998) , positive (Pivac et al., 1997b) or paranoid (Muck-Seler et al., 1991) symptoms of schizophrenia, supporting the hypothesis that platelet 5-HT concentration is related to trait markers (Askenazy et al., 2000; Peirson et al., 1999) , such as psychotic symptoms in PTSD (present study). Our data suggest that platelet 5-HT may distinguish between PTSD subjects with and without psychotic symptoms. In line with previous data (Maguire et al., 1998; Mellman and Kumar, 1994; Muck-Seler et al., 2003; Pivac et al., 2002) , our veterans with or without combat related PTSD had similar platelet 5-HT concentration as control subjects or combat exposed veterans who did not develop PTSD, indicating that platelet 5-HT is not associated with diagnosis of PTSD (van Praag, 2004) . Platelet 5-HT concentration might be affected by sex, age or seasonality. The effect of sex was excluded with the inclusion of only male subjects; the possible effect of age on platelet 5-HT content was 6 6 neglected as no significant relation between age and platelet 5-HT was found in healthy (Muck-Seler et al., 1996b; Pivac et al., 2001; Pivac et al., 2004b) or PTSD (present study) subjects, and the possible seasonal influence on platelet 5-HT parameters (Jakovljevic et al., 1997) was avoided since war veterans and healthy controls were sampled in the same season.
The lack of significant relationship between platelet 5-HT and other subscales of PANSS or CAPS indicates that only delusions were associated with increased values of platelet 5-HT. In support to our data no association was found between platelet 5-HT and CAPS scores in less severely ill patients without psychotic symptoms (Pivac et al., 2002) , or between platelet 5-HT content and uptake and scores measuring PTSD, depressive and anxiety symptoms (Maguire et al., 1998; Mellman and Kumar, 1994) .
Although psychotic PTSD is not recognized as a separate entity, 30-40% of combat related PTSD patients develop psychotic symptoms, which add to a more severe form of PTSD (Butler et al., 1996; Hamner, 1997; Hamner et al., 1999; Mueser et al., 2002; KozaricKovacic and Borovecki, 2005; Kozaric-Kovacic and Kocijan-Hercigonja, 2001; KozaricKovacic et al., 2005; Pivac et al., 2004a) . Psychotic features in our PTSD patients were not due to previous comorbidity, as we excluded patients with previous Axis I disorders.
Increased concentration of cerebrospinal fluid corticotrophin releasing hormone (Sautter et al., 2003) , decreased activity of the plasma dopamine beta hydoxylase (Hamner and Gould, 1998) , and increased platelet 5-HT concentrations (present study) were found in psychotic PTSD, suggesting a biologically distinct psychotic PTSD subtype.
The limitation of the study was the use of peripheral marker, platelet 5-HT concentration. The advantage of the study was in the inclusion criteria of only drug-free war veterans with or without combat related PTSD, and/or psychotic symptoms, a large sample (N=138), and detailed clinical assessment with instrument measures such as SCID, CAPS and PANSS.
In conclusion, platelet 5-HT concentration was increased in war veterans with psychotic PTSD, and there was a significant relationship between psychotic symptoms, especially delusions, and platelet 5-HT concentration in these patients. The data suggest that platelet 5-HT concentration might be used as a trait marker for PTSD with psychotic features.
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